Paul Kelly - Nov 5, 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Operating Officer, Director
Signature
/s/ Paul Kelly
Stock symbol
RLMD
Transactions as of
Nov 5, 2025
Transactions value $
$198,000
Form type
4
Date filed
11/6/2025, 07:30 AM
Previous filing
Jun 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Paul Edward Chief Operating Officer, Director C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES, /s/ Paul Kelly 2025-11-06 0001658544

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $198K +90K +21.83% $2.20 502K Nov 5, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.